Management of Diabetes Mellitus and Hospital-related Hyperglycemia in Patients of a Medical ICU, with the Use of Two “Down-to-Earth” Protocols: A Feasibility Study

Abstract

Objective: Optimal control of blood glucose in the ICU has been shown to significantly decrease mortality and morbidity of severely ill patients. The purpose of the present project was to develop and implement undemanding, “down-to-earth” protocols, enabling tight glucose control in critically ill patients, in the setting of a city hospital ICU with limited personnel and facilities.

Research Design and Methods: From January 2003 to January 2006, a total of 745 patients (3197 patient-days) were treated for hyperglycemia in our medical ICU. On July 2003 two different intensive insulin therapy protocols were implemented: A protocol of continuous intravenous insulin, including specific algorithms for calculation of initial insulin bolus, initial infusion rate and further adjustment plan, was used for patients with compromised peripheral tissue perfusion. For patients with stable circulation, a protocol of subcutaneous intensive insulin therapy, including a formula for calculation of daily insulin dosage in previously non-insulin-treated diabetics, was adopted. 134 patients were treated during the run-in phase of the project and 539 patients were treated during the main treatment phase. 72 patients treated for hyperglycemia in our ICU prior to the implementation of the two protocols (from January 2003 to July 2003) served as controls.

Results: After the implementation of the two protocols, a marked overall increase of normoglycemic blood glucose values (64.7% vs. 48.5%, P<0.001), a decrease of manifest hyperglycemias (6.4% vs. 17.4%, P<0.001) and an increase in hypoglycemic events (1.8% vs. 0.7%, P<0.001) was observed. Seven cases of severe hypoglycemia requiring glucose infusion were observed during the main treatment phase (0.3%). No hypoglycemia-associated deaths occurred.

Conclusions: The combined implementation of the two protocols presents a simple, safe and effective way of pursuing normoglycemia in critically ill patients.

diabetes - ICU - intensive - insulin - protocol

References

• 1 Conner TM, Flesner-Gurley KR, Barner JC. Hyperglycemia in the hospital setting: the case for improved control among non-diabetics.  Ann Pharmacother. 2005;  39 492-501
• 2 Digman C, Borto D, Nasraway SA. Hyperglycemia in the critically ill.  Nutr Clin Care. 2005;  8 93-101
• 3 DiNardo MM, Korytkowski MT, Siminerio LS. The importance of normoglycemia in critically ill patients.  Crit Care Nurs Q. 2004;  27 126-134
• 4 Ellison JM, Stegmann JM, Colner SL, Michael RH, Sharma MK, Ervin KR, Horwitz DL. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites.  Diabetes Care. 2002;  25 961-964
• 5 Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.  J Thorac Cardiovasc Surg. 2003;  125 1007-1021
• 6 Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.  J Am Coll Cardiol. 1995;  26 57-65
• 7 Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.  Eur Heart J. 2005;  26 650-661
• 8 Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis.  Intensive Care Med. 2004;  30 748-756
• 9 Mesotten D, Berghe G Van den. Clinical potential of insulin therapy in critically ill patients.  Drugs. 2003;  63 625-636
• 10 Nylen ES, Muller B. Endocrine changes in critical illness.  J Intensive Care Med. 2004;  19 67-82
• 11 Robinson LE, Soeren MH van. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.  AACN Clin Issues. 2004;  15 45-62
• 12 ONETOUCH® Ultra™ . Report from an evaluation organised by SKUP.  2005;  http://www.uib.no/isf/noklus/skup/pdf/otuglu.pdf
• 13 Solano T, Totaro R. Insulin therapy in critically ill patients.  Curr Opin Clin Nutr Metab Care. 2004;  7 199-205
• 14 Taylor JH, Beilman GJ. Hyperglycemia in the intensive care unit: no longer just a marker of illness severity.  Surg Infect (Larchmt). 2005;  6 233-245
• 15 Van den Berghe G. Beyond diabetes: saving lives with insulin in the ICU.  Int J Obes Relat Metab Disord. 2002;  26 (Suppl 3) S3-8
• 16 Berghe G Van den. How does blood glucose control with insulin save lives in intensive care?.  J Clin Invest. 2004;  114 1187-1195
• 17 Berghe G Van den. Insulin therapy for the critically ill patient.  Clin Cornerstone. 2003;  5 56-63
• 18 Berghe G Van den, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Wijngaerden E Van, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU.  N Engl J Med. 2006;  354 449-461
• 19 Berghe G Van den, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-1367
• 20 Berghe GH Van den. Role of intravenous insulin therapy in critically ill patients.  Endocr Pract. 2004;  10 (Suppl 2) 17-20
• 21 Weinzimer SA, Beck RW, Chase HP, Fox LA, Buckingham BA, Tamborlane WV, Kollman C, Coffey J, Xing D, Ruedy KJ. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study.  Diabetes Technol Ther. 2005;  7 675-680 , discussion 681-673

Correspondence